Indeed, HIFs are considered master regulators of cancer progression [12,13,14,15] by up-regulation of target genes involved in angiogenesis, immune evasion, and metabolic reprogramming of cancer cells [16], making them resistant to ChT and RT [17,18]. This evidence concerns the gene SLC5A7 and cancer.